Search
for
Sort by
Research 271–300 of 790
- Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Androgens in women
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Androgenic Hormone Profile of Adult Women with Acne
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Endocrine evaluation of hirsutism
- Obesity and the Polycystic Ovary Syndrome
- Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)
- Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Hormone therapy in acne
- Alterations in androgen conjugate levels in women and men with alopecia
- Relationships Between Biochemical Markers of Hyperandrogenism and Metabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Acne severity and the Global Acne Grading System in polycystic ovary syndrome
- The Hirsute Woman: Challenges in Evaluation and Management
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Female Adolescent Hair Disorders
- Antiandrogen Therapy for Skin and Hair Disease
- Impact of Treatment with Rosiglitazone or Metformin on Biomarkers for Insulin Resistance and Metabolic Syndrome in Patients with Polycystic Ovary Syndrome
- Ovarian morphology is associated with insulin resistance in women with polycystic ovary syndrome: a cross sectional study
- Systemic causes of hair loss
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Polycystic Ovarian Syndrome in Adolescents
- Do Different Diagnostic Criteria Impact Polycystic Ovary Syndrome Diagnosis for Adolescents?
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Is there association between thyroid stimulating hormone levels and the four phenotypes in polycystic ovary syndrome?